Optical coherence tomography, fluorescein angiography, and the management of neovascular age-related macular degeneration

Ophthalmology

Volumn 122, Issue 2, 2015, Pages 222-223

  Schachat, Andrew P ^a   Thompson, John T ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; RANIBIZUMAB;

AGE RELATED MACULAR DEGENERATION; BEST CORRECTED VISUAL ACUITY; EDITORIAL; FLUORESCENCE ANGIOGRAPHY; HUMAN; NEOVASCULAR AGE RELATED MACULAR DEGENERATION; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; PROCEDURES; VISUAL SYSTEM EXAMINATION; WET MACULAR DEGENERATION;

DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; HUMANS; TOMOGRAPHY, OPTICAL COHERENCE; WET MACULAR DEGENERATION;

EID: 84921452843     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2014.09.015     Document Type: Editorial

References (11)

1. M.M. Castillo, G. Mowatt, and A. Elders Optical coherence tomography for the monitoring of neovascular age-related macular degeneration: a systematic review Ophthalmology 122 2015 399 406
2. D.M. Brown, M. Michels, and P.K. Kaiser Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study Ophthalmology 116 2009 57 65
3. P.J. Rosenfeld, D.M. Brown, J.S. Heier for the MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Eng J Med 355 2006 1419 1431
4. J.S. Heier, D.M. Brown, and V. Chong Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration Ophthalmology 119 2012 2537 2548
5. Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration. Two-year results Ophthalmology 119 2012 1388 1398
6. The IVAN Study Investigators Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration. One-year findings from the IVAN randomized trial Ophthalmology 119 2012 1399 1411
7. K. Berg, T.R. Pedersen, L. Sandvik, and R. Bragadóttir Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol Ophthalmology 122 2015 146 152
8. N.M. Bressler, L. Frost, S.B. Bressler, and S.L. Fine Natural course of poorly defined choroidal neovascularization in macular degeneration Arch Ophthalmol 106 1988 1537 1542
9. Age-Related Eye Disease Study Research Group A simplified severity scale for age-related macular degeneration. AREDS report no. 18 Arch Ophthalmol 123 2005 1570 1574
10. M.G. Maguire, A.E. Shah, and J.E. Grunwald Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials Ophthalmology 120 2013 2035 2041
11. The AREDS2-HOME Study Research Group Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the eye (HOME) study Ophthalmology 121 2014 535 544